RU2407734C2 - Способ получения бис(тиогидразидамидной) дисоли (варианты) - Google Patents

Способ получения бис(тиогидразидамидной) дисоли (варианты) Download PDF

Info

Publication number
RU2407734C2
RU2407734C2 RU2007144216/04A RU2007144216A RU2407734C2 RU 2407734 C2 RU2407734 C2 RU 2407734C2 RU 2007144216/04 A RU2007144216/04 A RU 2007144216/04A RU 2007144216 A RU2007144216 A RU 2007144216A RU 2407734 C2 RU2407734 C2 RU 2407734C2
Authority
RU
Russia
Prior art keywords
methyl
bis
thiohydrazidamide
phenyl
organic solvent
Prior art date
Application number
RU2007144216/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2007144216A (ru
Inventor
Шоуджун ЧЕН (US)
Шоуджун ЧЕН
Жи-Кианг КСИА (US)
Жи-Кианг КСИА
Original Assignee
Синта Фармасьютиклз Корп.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Синта Фармасьютиклз Корп. filed Critical Синта Фармасьютиклз Корп.
Publication of RU2007144216A publication Critical patent/RU2007144216A/ru
Application granted granted Critical
Publication of RU2407734C2 publication Critical patent/RU2407734C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/38Amides of thiocarboxylic acids
    • C07C327/56Amides of thiocarboxylic acids having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2007144216/04A 2005-05-16 2006-05-11 Способ получения бис(тиогидразидамидной) дисоли (варианты) RU2407734C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68126305P 2005-05-16 2005-05-16
US60/681,263 2005-05-16

Publications (2)

Publication Number Publication Date
RU2007144216A RU2007144216A (ru) 2009-06-27
RU2407734C2 true RU2407734C2 (ru) 2010-12-27

Family

ID=37057197

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007144216/04A RU2407734C2 (ru) 2005-05-16 2006-05-11 Способ получения бис(тиогидразидамидной) дисоли (варианты)

Country Status (16)

Country Link
US (1) US7709683B2 (enExample)
EP (1) EP1888520A2 (enExample)
JP (1) JP2008540658A (enExample)
KR (1) KR20080008399A (enExample)
CN (1) CN101223133B (enExample)
AU (1) AU2006247470B2 (enExample)
BR (1) BRPI0611262A2 (enExample)
CA (1) CA2607890A1 (enExample)
IL (1) IL187056A (enExample)
MX (1) MX2007014314A (enExample)
NO (1) NO20075707L (enExample)
NZ (1) NZ563124A (enExample)
RU (1) RU2407734C2 (enExample)
TW (1) TWI387579B (enExample)
WO (1) WO2006124736A2 (enExample)
ZA (1) ZA200709395B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI332943B (en) 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
WO2006009940A1 (en) 2004-06-23 2006-01-26 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) salts for treatment of cancers
JP5204489B2 (ja) * 2004-11-19 2013-06-05 シンタ ファーマスーティカルズ コーポレイション Hsp70発現を増加するためのビス(チオ‐ヒドラジドアミド)
NZ562572A (en) * 2005-04-15 2011-01-28 Synta Pharmaceuticals Corp Combination cancer therapy with BIS (thiohydrazide) amide compounds
WO2006113572A1 (en) * 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of increasing natural killer cell activity for therapy
KR20080035642A (ko) 2005-08-16 2008-04-23 신타 파마슈티칼스 코프. 비스(티오-히드라지드 아미드) 제제
US20100068174A1 (en) * 2006-08-21 2010-03-18 Synta Pharmaceuticals Corp. Combination with bis (thiohydrazide amides) for treating cancer
WO2008024301A2 (en) * 2006-08-21 2008-02-28 Synta Pharmaceuticals Corp. Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
US20080226588A1 (en) * 2006-08-21 2008-09-18 Mcleod Matthew Treating melanoma with bis(thiohydrazide amides)
RU2475478C2 (ru) 2006-08-21 2013-02-20 Синта Фармасьютиклз Корп. Соединения для лечения пролиферативных расстройств
JP2010502616A (ja) * 2006-08-31 2010-01-28 シンタ ファーマシューティカルズ コーポレーション 癌を治療するためのビス(チオヒドラジドアミド)の組み合わせ
US9498528B2 (en) * 2006-09-13 2016-11-22 Genzyme Corporation Treatment of multiple sclerosis (MS)
WO2008033494A2 (en) 2006-09-15 2008-03-20 Synta Pharmaceuticals Corp. Purification of bis(thiohydrazide amides)
WO2009064374A2 (en) 2007-11-09 2009-05-22 Synta Pharmaceuticals Corp. Oral formulations of bis(thiohydrazide amides)
WO2009105257A1 (en) 2008-02-21 2009-08-27 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
WO2009123704A2 (en) * 2008-03-31 2009-10-08 Synta Pharmaceuticals Corp. Process for preparing bis(thiohydrazide amides)
AU2009308511B2 (en) 2008-10-22 2013-03-07 Synta Pharmaceutical Corp. Transition metal complexes of a bis[thiohydrazide amide] compound
CA2741189A1 (en) 2008-10-22 2010-04-29 Synta Pharmaceuticals Corp. Transition metal complexes of bis[thiohydrazide amide] compounds
US8525776B2 (en) * 2008-10-27 2013-09-03 Lenovo (Singapore) Pte. Ltd Techniques for controlling operation of a device with a virtual touchscreen
AU2009322603B2 (en) 2008-12-01 2013-08-29 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
WO2011069159A2 (en) 2009-12-04 2011-06-09 Synta Pharmaceuticals Corp. Bis[thiohydrazide amide] compounds for treating leukemia
WO2011133673A1 (en) 2010-04-20 2011-10-27 Synta Pharmaceuticals Corp. Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2097737A5 (en) 1970-07-14 1972-03-03 Berlin Chemie Veb Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
DE2037257A1 (en) 1970-07-28 1972-02-03 Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
US4012360A (en) 1973-12-03 1977-03-15 Ciba-Geigy Corporation Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
JPS5091056A (enExample) 1973-12-17 1975-07-21
US6013836A (en) 1992-02-28 2000-01-11 Rohm And Haas Company Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
FR2697752B1 (fr) 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
ATE184613T1 (de) 1995-09-22 1999-10-15 Novo Nordisk As Varianten des grünen fluoreszenzproteins, gfp
US6235787B1 (en) 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
TW479053B (en) 1998-10-19 2002-03-11 Agro Kanesho Co Ltd Hydrazineoxoacetamide derivatives and pesticides
ES2161594B1 (es) 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
US6322303B1 (en) 2000-05-12 2001-11-27 David M. John Dunnage bag and method of making same
EP1164126A1 (de) 2000-06-16 2001-12-19 Basf Aktiengesellschaft Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
US6365745B1 (en) 2000-07-14 2002-04-02 Sumika Fine Chemicals Co., Ltd. Method for producing hydrazine derivative
WO2002059080A2 (en) 2001-01-25 2002-08-01 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
US6924312B2 (en) * 2001-07-10 2005-08-02 Synta Pharmaceuticals Corp. Taxol enhancer compounds
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI297335B (en) * 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TW200408407A (en) * 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
TWI330079B (en) * 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
WO2006009940A1 (en) * 2004-06-23 2006-01-26 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) salts for treatment of cancers
WO2006033913A2 (en) 2004-09-16 2006-03-30 Synta Pharmaceuticals Corp. Bis (thio-hydrazide amides) for treament of hyperplasia
JP5204489B2 (ja) * 2004-11-19 2013-06-05 シンタ ファーマスーティカルズ コーポレイション Hsp70発現を増加するためのビス(チオ‐ヒドラジドアミド)
WO2006113572A1 (en) 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of increasing natural killer cell activity for therapy
NZ562572A (en) 2005-04-15 2011-01-28 Synta Pharmaceuticals Corp Combination cancer therapy with BIS (thiohydrazide) amide compounds
WO2006113493A2 (en) 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of determining cancer prognosis via natural killer cell activity
KR20080035642A (ko) * 2005-08-16 2008-04-23 신타 파마슈티칼스 코프. 비스(티오-히드라지드 아미드) 제제

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Яровенко В.Н., Широков А.В. и др. Журнал Органической Химии, 39(8), 2003, 1204-1210. *

Also Published As

Publication number Publication date
TW200722411A (en) 2007-06-16
NO20075707L (no) 2007-12-11
EP1888520A2 (en) 2008-02-20
JP2008540658A (ja) 2008-11-20
CA2607890A1 (en) 2006-11-23
BRPI0611262A2 (pt) 2010-08-24
WO2006124736A3 (en) 2007-03-29
IL187056A0 (en) 2008-02-09
MX2007014314A (es) 2008-02-11
CN101223133B (zh) 2012-02-29
US20060270873A1 (en) 2006-11-30
ZA200709395B (en) 2008-10-29
TWI387579B (zh) 2013-03-01
AU2006247470A1 (en) 2006-11-23
RU2007144216A (ru) 2009-06-27
AU2006247470B2 (en) 2010-04-01
IL187056A (en) 2013-10-31
WO2006124736A2 (en) 2006-11-23
NZ563124A (en) 2010-12-24
KR20080008399A (ko) 2008-01-23
US7709683B2 (en) 2010-05-04
CN101223133A (zh) 2008-07-16

Similar Documents

Publication Publication Date Title
RU2407734C2 (ru) Способ получения бис(тиогидразидамидной) дисоли (варианты)
RU2007101898A (ru) Соли бис (тиогидразидамида) для лечения рака
AU2002354641B2 (en) Taxol enhancer compounds
AU2002316626B2 (en) Taxol enhancer compounds
AU2002316626A1 (en) Taxol enhancer compounds
US20080176852A1 (en) Biguanide and dihydrotriazine derivatives
US20030195258A1 (en) Taxol enhancer compounds
AU2002354641A1 (en) Taxol enhancer compounds
MXPA04000245A (es) Sintesis de mejoradores de taxol.
JPS6094960A (ja) 新規ニトロキシル化合物、その製法およびこれを含有するnmr診断剤
AU2013302390A1 (en) Stat3 inhibitors and their anticancer use
WO2009073147A2 (en) Process for preparing bis(thiohydrazide amides)
ES2356379T3 (es) Compuestos potenciadores de taxol.
JP2009517412A5 (enExample)
ES2432525T3 (es) Pirroles sustituidos terapéuticos
CN102603553B (zh) 具有协同抗真菌作用的化合物及其在药学中的用途
EP3897592B1 (en) Compounds for the inhibition of unregulated cell growth
JP2013540141A (ja) 置換n−(3−アミノ−キノキサリン−2−イル)−スルホンアミドおよびそれらの中間体n−(3−クロロ−キノキサリン−2−イル)スルホンアミドを調製する方法
RU2012136831A (ru) Синтез замещенных производных пиразолин карбоксамидина
EA050328B1 (ru) Косметические соединения
BR102024004709A2 (pt) Método de fabricação de um derivado de eugenol, composto derivado de eugenol e uso de um composto derivado de eugenol
WO2016005407A1 (en) One-pot synthesis of squaramides
ZA200505039B (en) Biguanide and dihydrotriazine derivatives
RU2010120015A (ru) Терапевтические замещенные лактамы

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20120512